KRAS and pancreatic neoplasm: In the commonly used LSL-KrasG12D/+; Pdx-1-Cre (KC) mouse model [48] with an activating Kras mutation targeted to the pancreas, pancreatitis accelerates the development of pancreatic cancer [49,50].